Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0286 Transporter Info | ||||
Gene Name | SLC34A3 | ||||
Transporter Name | Sodium-dependent phosphate transport protein 2C | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC34A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg21964481) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:5.68E-06; Z-score:-9.99E-01 | ||
Methylation in Case |
9.11E-01 (Median) | Methylation in Control | 9.28E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC34A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg05036153) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:1.18E-03; Z-score:2.65E-01 | ||
Methylation in Case |
1.84E-01 (Median) | Methylation in Control | 1.66E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC34A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg07620167) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:4.61E-03; Z-score:2.83E-01 | ||
Methylation in Case |
8.61E-02 (Median) | Methylation in Control | 7.90E-02 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC34A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg13431678) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.69E+00 | Statistic Test | p-value:3.60E-02; Z-score:-5.28E-01 | ||
Methylation in Case |
7.88E-02 (Median) | Methylation in Control | 1.33E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC34A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg13505608) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.29E+00 | Statistic Test | p-value:3.66E-02; Z-score:-8.65E-01 | ||
Methylation in Case |
1.66E-01 (Median) | Methylation in Control | 2.14E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC34A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg13512859) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:3.68E-02; Z-score:1.82E-01 | ||
Methylation in Case |
9.01E-01 (Median) | Methylation in Control | 8.90E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC34A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg13701954) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:3.83E-02; Z-score:-5.15E-01 | ||
Methylation in Case |
8.78E-01 (Median) | Methylation in Control | 9.10E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC34A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg13716321) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:3.85E-02; Z-score:3.74E-01 | ||
Methylation in Case |
9.03E-01 (Median) | Methylation in Control | 8.44E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC34A3 in breast cancer | [ 2 ] | |||
Location |
5'UTR (cg21964481) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:4.53E-05; Z-score:8.20E-01 | ||
Methylation in Case |
6.44E-01 (Median) | Methylation in Control | 6.08E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC34A3 in breast cancer | [ 2 ] | |||
Location |
Body (cg13716321) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:1.59E-04; Z-score:1.65E+00 | ||
Methylation in Case |
5.33E-01 (Median) | Methylation in Control | 4.87E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC34A3 in breast cancer | [ 2 ] | |||
Location |
Body (cg13512859) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:1.90E-03; Z-score:1.03E+00 | ||
Methylation in Case |
4.23E-01 (Median) | Methylation in Control | 3.81E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC34A3 in breast cancer | [ 2 ] | |||
Location |
Body (cg13505608) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:2.34E-03; Z-score:1.11E+00 | ||
Methylation in Case |
6.20E-01 (Median) | Methylation in Control | 5.63E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC34A3 in breast cancer | [ 2 ] | |||
Location |
Body (cg13701954) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:1.75E-02; Z-score:9.01E-01 | ||
Methylation in Case |
5.74E-01 (Median) | Methylation in Control | 5.27E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC34A3 in colorectal cancer | [ 3 ] | |||
Location |
5'UTR (cg21964481) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:4.88E-05; Z-score:1.13E+00 | ||
Methylation in Case |
7.21E-01 (Median) | Methylation in Control | 6.48E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC34A3 in colorectal cancer | [ 3 ] | |||
Location |
Body (cg13716321) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:1.01E-04; Z-score:-1.02E+00 | ||
Methylation in Case |
7.72E-01 (Median) | Methylation in Control | 8.22E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC34A3 in hepatocellular carcinoma | [ 4 ] | |||
Location |
5'UTR (cg08360771) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.51E+00 | Statistic Test | p-value:2.81E-13; Z-score:-3.28E+00 | ||
Methylation in Case |
3.91E-01 (Median) | Methylation in Control | 5.92E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC34A3 in hepatocellular carcinoma | [ 4 ] | |||
Location |
5'UTR (cg21964481) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:1.07E-03; Z-score:-2.36E-01 | ||
Methylation in Case |
6.40E-01 (Median) | Methylation in Control | 6.52E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC34A3 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS200 (cg26681123) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.14E+00 | Statistic Test | p-value:4.50E-05; Z-score:-1.16E+00 | ||
Methylation in Case |
5.77E-01 (Median) | Methylation in Control | 6.56E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC34A3 in hepatocellular carcinoma | [ 4 ] | |||
Location |
Body (cg13505608) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.11E+00 | Statistic Test | p-value:2.72E-08; Z-score:-1.24E+00 | ||
Methylation in Case |
7.10E-01 (Median) | Methylation in Control | 7.87E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC34A3 in hepatocellular carcinoma | [ 4 ] | |||
Location |
Body (cg07620167) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.18E+00 | Statistic Test | p-value:2.16E-07; Z-score:-1.24E+00 | ||
Methylation in Case |
3.99E-01 (Median) | Methylation in Control | 4.71E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC34A3 in hepatocellular carcinoma | [ 4 ] | |||
Location |
Body (cg13716321) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:3.97E-03; Z-score:-8.23E-01 | ||
Methylation in Case |
5.63E-01 (Median) | Methylation in Control | 6.07E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC34A3 in HIV infection | [ 5 ] | |||
Location |
5'UTR (cg21964481) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:3.65E-03; Z-score:-1.28E+00 | ||
Methylation in Case |
7.85E-01 (Median) | Methylation in Control | 8.25E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC34A3 in HIV infection | [ 5 ] | |||
Location |
Body (cg13716321) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:1.26E-03; Z-score:4.91E-01 | ||
Methylation in Case |
6.96E-01 (Median) | Methylation in Control | 6.73E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC34A3 in HIV infection | [ 5 ] | |||
Location |
Body (cg13512859) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:4.93E-03; Z-score:-1.12E+00 | ||
Methylation in Case |
6.08E-01 (Median) | Methylation in Control | 6.49E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC34A3 in HIV infection | [ 5 ] | |||
Location |
Body (cg05036153) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.17E+00 | Statistic Test | p-value:5.15E-03; Z-score:-1.83E+00 | ||
Methylation in Case |
6.02E-01 (Median) | Methylation in Control | 7.03E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC34A3 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
5'UTR (cg26866142) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.31E+00 | Statistic Test | p-value:1.73E-06; Z-score:1.41E+00 | ||
Methylation in Case |
9.13E-01 (Median) | Methylation in Control | 6.95E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC34A3 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg14485581) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:1.79E-04; Z-score:1.01E+00 | ||
Methylation in Case |
8.24E-01 (Median) | Methylation in Control | 7.92E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC34A3 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
Body (cg05859929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:1.39E-07; Z-score:1.79E+00 | ||
Methylation in Case |
7.81E-01 (Median) | Methylation in Control | 7.05E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC34A3 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
Body (cg11945507) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:2.59E-04; Z-score:-9.35E-01 | ||
Methylation in Case |
6.05E-01 (Median) | Methylation in Control | 6.43E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC34A3 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
Body (cg21949830) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.13E+00 | Statistic Test | p-value:5.09E-03; Z-score:-1.11E+00 | ||
Methylation in Case |
5.95E-01 (Median) | Methylation in Control | 6.74E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC34A3 in papillary thyroid cancer | [ 7 ] | |||
Location |
5'UTR (cg21964481) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:2.69E-04; Z-score:-7.97E-01 | ||
Methylation in Case |
7.58E-01 (Median) | Methylation in Control | 7.88E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC34A3 in papillary thyroid cancer | [ 7 ] | |||
Location |
Body (cg05036153) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.15E+00 | Statistic Test | p-value:1.77E-03; Z-score:-9.31E-01 | ||
Methylation in Case |
4.66E-01 (Median) | Methylation in Control | 5.35E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC34A3 in colon adenocarcinoma | [ 8 ] | |||
Location |
TSS1500 (cg01337931) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:1.05E-03; Z-score:-1.88E+00 | ||
Methylation in Case |
7.08E-01 (Median) | Methylation in Control | 7.74E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC34A3 in colon adenocarcinoma | [ 8 ] | |||
Location |
Body (cg01218720) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:1.97E-04; Z-score:-3.18E+00 | ||
Methylation in Case |
8.82E-01 (Median) | Methylation in Control | 9.28E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC34A3 in bladder cancer | [ 9 ] | |||
Location |
TSS200 (cg26681123) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.27E+00 | Statistic Test | p-value:8.75E-08; Z-score:-5.94E+00 | ||
Methylation in Case |
5.98E-01 (Median) | Methylation in Control | 7.61E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC34A3 in bladder cancer | [ 9 ] | |||
Location |
Body (cg13701954) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.86E+00 | Statistic Test | p-value:2.74E-14; Z-score:-1.94E+01 | ||
Methylation in Case |
3.49E-01 (Median) | Methylation in Control | 6.50E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC34A3 in bladder cancer | [ 9 ] | |||
Location |
Body (cg05036153) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.72E+00 | Statistic Test | p-value:1.12E-12; Z-score:-1.28E+01 | ||
Methylation in Case |
1.76E-01 (Median) | Methylation in Control | 4.79E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC34A3 in bladder cancer | [ 9 ] | |||
Location |
Body (cg13431678) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.03E+00 | Statistic Test | p-value:2.92E-11; Z-score:-1.98E+01 | ||
Methylation in Case |
3.88E-01 (Median) | Methylation in Control | 7.86E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC34A3 in bladder cancer | [ 9 ] | |||
Location |
Body (cg13512859) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.99E+00 | Statistic Test | p-value:1.56E-10; Z-score:-9.05E+00 | ||
Methylation in Case |
2.54E-01 (Median) | Methylation in Control | 5.06E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC34A3 in bladder cancer | [ 9 ] | |||
Location |
Body (cg13505608) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.53E+00 | Statistic Test | p-value:4.08E-08; Z-score:-6.30E+00 | ||
Methylation in Case |
4.85E-01 (Median) | Methylation in Control | 7.43E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC34A3 in bladder cancer | [ 9 ] | |||
Location |
Body (cg13716321) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.43E+00 | Statistic Test | p-value:2.15E-06; Z-score:-5.43E+00 | ||
Methylation in Case |
3.90E-01 (Median) | Methylation in Control | 5.57E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC34A3 in bladder cancer | [ 9 ] | |||
Location |
Body (cg07620167) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.66E+00 | Statistic Test | p-value:8.59E-06; Z-score:-4.31E+00 | ||
Methylation in Case |
3.04E-01 (Median) | Methylation in Control | 5.03E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC34A3 in panic disorder | [ 10 ] | |||
Location |
TSS200 (cg26681123) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:2.64E-02; Z-score:4.51E-01 | ||
Methylation in Case |
2.78E+00 (Median) | Methylation in Control | 2.62E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC34A3 in panic disorder | [ 10 ] | |||
Location |
Body (cg13512859) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.21E+00 | Statistic Test | p-value:7.15E-03; Z-score:3.37E-01 | ||
Methylation in Case |
5.87E-01 (Median) | Methylation in Control | 4.83E-01 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC34A3 in panic disorder | [ 10 ] | |||
Location |
Body (cg07620167) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.16E+00 | Statistic Test | p-value:1.92E-02; Z-score:3.70E-01 | ||
Methylation in Case |
1.61E+00 (Median) | Methylation in Control | 1.39E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC34A3 in clear cell renal cell carcinoma | [ 11 ] | |||
Location |
Body (cg13505608) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.16E+00 | Statistic Test | p-value:1.02E-03; Z-score:2.56E+00 | ||
Methylation in Case |
8.00E-01 (Median) | Methylation in Control | 6.89E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC34A3 in clear cell renal cell carcinoma | [ 11 ] | |||
Location |
Body (cg07620167) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:6.83E-03; Z-score:1.09E+00 | ||
Methylation in Case |
4.94E-01 (Median) | Methylation in Control | 4.45E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Depression |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC34A3 in depression | [ 12 ] | |||
Location |
Body (cg13431678) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:2.21E-04; Z-score:-8.15E-01 | ||
Methylation in Case |
8.25E-01 (Median) | Methylation in Control | 8.44E-01 (Median) | ||
Studied Phenotype |
Depression[ ICD-11:6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC34A3 in depression | [ 12 ] | |||
Location |
Body (cg07620167) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:3.99E-03; Z-score:-6.92E-01 | ||
Methylation in Case |
7.22E-01 (Median) | Methylation in Control | 7.59E-01 (Median) | ||
Studied Phenotype |
Depression[ ICD-11:6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC34A3 in depression | [ 12 ] | |||
Location |
Body (cg13512859) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:3.30E-02; Z-score:-7.16E-01 | ||
Methylation in Case |
5.73E-01 (Median) | Methylation in Control | 5.93E-01 (Median) | ||
Studied Phenotype |
Depression[ ICD-11:6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC34A3 in depression | [ 12 ] | |||
Location |
Body (cg05036153) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:3.60E-02; Z-score:-7.52E-02 | ||
Methylation in Case |
6.04E-01 (Median) | Methylation in Control | 6.07E-01 (Median) | ||
Studied Phenotype |
Depression[ ICD-11:6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC34A3 in lung adenocarcinoma | [ 13 ] | |||
Location |
Body (cg13512859) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.10E+00 | Statistic Test | p-value:1.86E-02; Z-score:-1.49E+00 | ||
Methylation in Case |
5.33E-01 (Median) | Methylation in Control | 5.86E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC34A3 in systemic lupus erythematosus | [ 14 ] | |||
Location |
Body (cg13716321) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:7.78E-04; Z-score:2.38E-01 | ||
Methylation in Case |
7.71E-01 (Median) | Methylation in Control | 7.50E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC34A3 in systemic lupus erythematosus | [ 14 ] | |||
Location |
Body (cg05036153) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:4.98E-02; Z-score:-1.03E-01 | ||
Methylation in Case |
6.61E-01 (Median) | Methylation in Control | 6.73E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.